{
    "nct_id": "NCT04998682",
    "official_title": "TAD: Prospective Evaluation of Targeted Axillary Dissection After Neoadjuvant Systemic Therapy in Patients with Breast Cancer with Advanced Nodal Disease At Diagnosis",
    "inclusion_criteria": "* Women or men greater than or equal to 18 years.\n* Histologically confirmed invasive adenocarcinoma of the breast.\n* Clinical T0-4 N2-3 M0 at diagnosis (American Joint Committee on Cancer, 7th Edition)\n\n  * Assessment for cN2 disease will be performed by clinical exam and imaging. Patients should have pathologic level 1 and/or 2 axillary lymph nodes which are fixed/matted on physical exam.\n  * Cross-sectional imaging will be used to identify advanced nodal disease involving the axilla, infraclavicular, supraclavicular, and internal mammary regions, cN3 disease.\n* Patients must have biopsy proven involvement of the axillary lymph nodes.\n* Receipt of standard multiagent chemotherapy +/- targeted therapy based on tumor subtype.\n* Candidate for surgical management of breast cancer.\n* Ability to understand and willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of allergic reactions or hypersensitivity to radioactive lymph node mapping agents or blue dye.\n* Pregnancy.",
    "miscellaneous_criteria": ""
}